Clopidogrel Tablet
Product Images NDC 31722-759

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Clopidogrel (NDC 31722-759). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clopidogrel-figure1 (Clopidogrel Figure1)

FDA Label Image

Clopidogrel-figure2 (Clopidogrel Figure2)

FDA Label Image

Clopidogrel-figure3 (Clopidogrel Figure3)

FDA Label Image

Clopidogrel-figure4 (Clopidogrel Figure4)

FDA Label Image

Clopidogrel-figure5 (Clopidogrel Figure5)

This text appears to be a medical study comparing the effects of Placebo and Clopidogrel on certain events. The study mentions the percentage of events observed in both groups, as well as the proportional risk reduction for re-infarction. There is also a reference to the number of deaths. The text also mentions the timeline of the study, specifically the days since randomization (up to 28 days). Overall, it seems to be a clinical evaluation of the two medications.*

FDA Label Image

Clopidogrel-figure6 (Clopidogrel Figure6)

FDA Label Image

Clopidogrel-figure7 (Clopidogrel Figure7)

FDA Label Image

Clopidogrel-figure8 (Clopidogrel Figure8)

FDA Label Image

Clopidogrel-structure (Clopidogrel Structure)

FDA Label Image

Clopidogrel-tablets-300mg-30s-container (Clopidogrel Tablets 300mg 30s Container)

FDA Label Image

Clopidogrel-tablets-75mg-30s-container (Clopidogrel Tablets 75mg 30s Container)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.